Keith Wilson
Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer enter · Vanderbilt University Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Keith Wilson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:27 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02794428 · Chemoprevention of Gastric CarcinogenesisVanderbilt-Ingram Cancer Center · completed · Gastric Cancer, Gastric Intestinal Metaplasia · principal investigator
- N/ANCT01091558 · Study of Effects of L-Arginine in Colitis and Colon CancerVanderbilt University Medical Center · completed · Ulcerative Colitis, Colon Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 17:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Inhibitors of the Reverse Transsulfuration Pathway as a New Treatment for Helicobacter pylori InfectionR21AI196953 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2026 · $481,250 awarded in 2026Same name and institution; not confirmed by an ID
- Pilot and Feasibility ProgramP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2017 to 2026 · $322,180 awarded in 2026Same name and institution; not confirmed by an ID
- Polyamines and Electrophiles in Gastric CancerP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2014 to 2026 · $322,421 awarded in 2026Same name and institution; not confirmed by an ID
- Spermidine as a New Therapy for Colitis and Chemopreventive for Colitis-associated CarcinogenesisR01DK128200 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2021 to 2024 · $648,415 awarded in 2024Same name and institution; not confirmed by an ID
- The Macrophage Reverse Transsulfuration Pathway: A Novel Mediator of Helicobacter pylori ImmunopathogenesisR21AI142042 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2019 to 2020 · $212,500 awarded in 2020Same name and institution; not confirmed by an ID
- Etiological Studies of Gastric CarcinomaP01CA028842 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2009 to 2019 · $1,007,531 awarded in 2019Same name and institution; not confirmed by an ID
- Targeted chemoprevention of gastric carcinogenesis in high risk populationsR01CA190612 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2014 to 2018 · $568,634 awarded in 2018Grant number is on one of their registry trials
- Immunomodulatory effects of arginine supplementation in colitis and colon cancerR01AT004821 · NCCIH · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2008 to 2017 · $395,000 awarded in 2017Grant number is on one of their registry trials
- H. pylori induced DNA Damage and Immune DysregulationR01DK053620 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2000 to 2014 · $32,101 awarded in 2014Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 17:27 UTC. The ranking covers the 200 most relevant of 257 PubMed records, and a shared surname and initials can bring in a namesake. All 257 on PubMed
- Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.N Engl J Med · 19971,359 citationsRCR 42.1
- Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.N Engl J Med · 2010761 citationsRCR 18.4
- 678 citationsRCR 30.5
- Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis.Am J Respir Crit Care Med · 2006365 citationsRCR 8.5
- 343 citationsRCR 7.8
- 341 citationsRCR 11.9
- ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial.JACC Cardiovasc Interv · 2021232 citationsRCR 15.7
- 220 citationsRCR 13.6
- A precision therapy against cancers driven by KIT/PDGFRA mutations.Sci Transl Med · 2017175 citationsRCR 5.3
- Cognitive-behavioral treatment of insomnia secondary to chronic pain.J Consult Clin Psychol · 2000170 citationsRCR 6.1